Masaki Yoshida
- Urology top 0.05%
- Urinary Bladder and Prostate Research 69
- Rheumatology top 0.5%
- Pelvic floor disorders treatments 30
- Clinical Biochemistry top 0.5%
-
- Hormonal and reproductive studies 21
- Hormonal Regulation and Hypertension 7
- Epidemiology top 5%
- Urinary Tract Infections Management 30
-
- Prostate Cancer Diagnosis and Treatment 11
- Renal and Vascular Pathologies 7
-
- Sexual function and dysfunction studies 7
- Co-authors
- Yukio HommaMomokazu GotohOsamu YokoyamaShoichi UedaOsamu YamaguchiMasayuki TakedaOsamu NishizawaKazuki Kawabe
- Partner nations
- JapanUnited StatesFrance
In The Last Decade
Masaki Yoshida
136 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Urology 2.3k
- Rheumatology 1.5k
- Clinical Biochemistry 488
- Endocrinology, Diabetes and Metabolism 781
- Epidemiology 923
Countries citing papers authored by Masaki Yoshida
This map shows the geographic impact of Masaki Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Yoshida more than expected).
Fields of papers citing papers by Masaki Yoshida
This network shows the impact of papers produced by Masaki Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Yoshida. The network helps show where Masaki Yoshida may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masaki Yoshida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2022 | 2 | |
| 3 | 2016 | 0 | |
| 4 | Intravesical application of rebamipide suppresses bladder inflammation and overactivity in a rat model | 2013 | 1 |
| 5 | Clinical outcomes of imidafenacin in addition to tamsulosin for patients with overactive bladder and benign prostatic hyperplasia (Addition study) | 2012 | 1 |
| 6 | 2011 | 25 | |
| 7 | 2011 | 32 | |
| 8 | 2010 | 9 | |
| 9 | 2008 | 15 | |
| 10 | PREDICTIVE FACTORS FOR THE EFFECT OF ALPHA1- ADRENOCEPTOR ANTAGONIST ON SUBJECTIVE AND OBJECTIVE PARAMETERS IN PATIENTS WITH NEUROGENIC LOWER URINARY TRACT DYSFUNCTION: SPECIAL FOCUS ON ALPHA1-D/A ADRENOCEPTOR ANTAGONIST NAFTOPIDIL | 2007 | 1 |
| 11 | 2006 | 214 | |
| 12 | 2005 | 18 | |
| 13 | 2004 | 7 | |
| 14 | 2002 | 45 | |
| 15 | 1999 | 1 | |
| 16 | 1998 | 23 | |
| 17 | 1998 | 39 | |
| 18 | 1995 | 2 | |
| 19 | Effect of T-3262 and its structural derivatives on GABA receptor binding | 1988 | 5 |
| 20 | 1987 | 2 |
About Masaki Yoshida
Masaki Yoshida is a scholar working on Urology, Rheumatology and Endocrinology, Diabetes and Metabolism, having authored 143 papers that have together received 4.2k indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (69 papers), Pelvic floor disorders treatments (30 papers), Urinary Tract Infections Management (30 papers), Hormonal and reproductive studies (21 papers), Prostate Cancer Diagnosis and Treatment (11 papers), Sexual function and dysfunction studies (7 papers), Hormonal Regulation and Hypertension (7 papers) and Renal and Vascular Pathologies (7 papers). The work is most often cited by research in Urology (2.3k citations), Rheumatology (1.5k citations) and Clinical Biochemistry (488 citations). Masaki Yoshida has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Yukio Homma, Momokazu Gotoh, Osamu Yokoyama, Shoichi Ueda, Osamu Yamaguchi, Masayuki Takeda, Osamu Nishizawa, Kazuki Kawabe, Tomonori Yamanishi and Hidehiro Κakizaki. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.